Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia

Chest

Volumn 122, Issue 1, 2002, Pages 262-268

  Iregui, Manuel ^a   Ward, Suzanne ^a   Sherman, Glenda ^b   Fraser, Victoria J ^a   Kollef, Marin H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

Author keywords

Antibiotics; Intensive care; Mechanical ventilation; Outcomes; Pneumonia; Resistance

Indexed keywords

ANTIBIOTIC AGENT; CEFEPIME; CIPROFLOXACIN; IMIPENEM; PIPERACILLIN; TAZOBACTAM; VANCOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM ISOLATE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; FEMALE; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; VENTILATOR;

EID: 0036304245     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.1.262     Document Type: Article

References (26)

1. Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients
2. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia
3. Modifications of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit: ICU-Acquired Pneumonia Study Group
4. The value of routine microbial investigation in ventilator-associated pneumonia
5. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient
6. The influence of mini-BAL cultures on patient outcomes: Implications for the antibiotic management of ventilator-associated pneumonia
7. Inadequate antimicrobial treatment: An important determinant of outcome for hospitalized patients
8. Determinants of weaning and survival among patients with COPD who require mechanical ventilation for acute respiratory failure
9. APACHE II: A severity of disease classification system
10. Patient selection for clinical investigation of ventilator-associated pneumonia: Criteria for evaluating diagnostic techniques
11. Diagnostic efficiency of endotracheal aspirates with quantitative bacterial cultures in intubated patients with suspected pneumonia: Comparison with the protected specimen brush
12. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia
13. The risk of determining risk with multivariable models
14. Pneumonia mortality reduction and quality improvement in a community hospital
15. Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia
16. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in ICU setting
17. Incidence and susceptibility of pathogenic bacteria vary between intensive care units within a single hospital: Implications for empiric antibiotic strategies
18. Variations in etiology of ventilator-associated pneumonia across four treatment sites: Implications for antimicrobial prescribing practices
19. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria
20. Mortality of nosocomial pneumonia in ventilated patients: Influence of diagnostic tools
21. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia
22. Nosocomial infections in medical intensive care units in the United States: National Nosocomial Infections Surveillance Systems System
23. Short course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: A proposed solution for indiscriminate antibiotic prescription
24. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia